Research Article
Fetal Fibronectin as a Predictor of Preterm Delivery: A Nigerian Cohort Study
Table 2
Maternal clinical characteristics and test results.
| Variable | Case (n,%) | Control (n,%) | X2 | p-value |
| GA at test | | | 0.58 | 0.75 | >30 wks | 10 (10.4) | 7 (7.3) | | | 30-36 wks | 67 (69.8) | 69 (71.9) | | | >36 wks | 19 (19.8) | 20 (20.8) | | | Cervical dilatation | | | — | — | <3 cm | 96 (100) | 96 (100) | | | ≥3 cm | 0 | 0 | | | Test result | | | | | Negative | 45 (46.9) | 83 (86.5) | | | Positive | 51 (53.1) | 13 (13.5) | | | GA at delivery | | | 30.92 | 0.001 | <34wks+6 | 21 (21.9) | 1 (1.04) | | | 34-36wks+6 | 25 (26.0) | 12 (12.5) | | | ≥37wks | 50 (52.08) | 83 (86.5) | | | History of preterm delivery | | | 0.19 | 0.41 | NO | 85 (88.5) | 83 (86.5) | | | YES | 11 (11.5) | 13 (13.5) | | | Admitted after test | | | 192.0 | 0.001 | No | 0 | 96 (100) | | | Yes | 96 (100) | 0 | | |
|
|